Celerion Inc.

Celerion Inc., headquartered in the United States, has made significant commitments towards reducing its carbon emissions and addressing climate change. Although specific emissions data for the most recent year is not available, the company has pledged to achieve net-zero emissions by 2050. This commitment aligns with the Science Based Targets initiative (SBTi) and aims to limit global temperature rise to 1.5°C.

Celerion's long-term reduction targets encompass all scopes of emissions, reflecting a comprehensive approach to sustainability. The company is actively working towards these ambitious goals, having initiated its commitment in 2023. As part of its climate strategy, Celerion is focused on implementing measures that will contribute to significant reductions in greenhouse gas emissions across its operations.

While detailed emissions figures are currently unavailable, Celerion's proactive stance in setting long-term targets demonstrates its dedication to environmental stewardship within the pharmaceuticals, biotechnology, and life sciences sector. The company's efforts are crucial in the broader context of corporate responsibility and climate action.